$9.740
-0.365 (-3.75%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
GLUE Prediction & Forecast by Similar Chart Analysis
Alphio's GLUE stock price prediction model matches the current Monte Rosa Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.81 (+0.75%). The 1-week path is $10.20 (+4.72%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Monte Rosa Therapeutics Inc Stock?
Monte Rosa Therapeutics Inc (GLUE) is currently not a strong buy due to its recent price decline and negative sentiment, despite a current price of $9.74 and a forward P/E of 10.02. The RSI is at 29.94, indicating it is oversold, but the stock has seen a 36.38% decline year-to-date, suggesting caution. The main risk is the insider selling activity, which increased by 122.61% over the last month, indicating potential lack of confidence from insiders.
GLUE stock price ended at $9.74 on Friday, after losing -3.75%
Monte Rosa Therapeutics Inc (GLUE) last closed at $9.74, losing -3.75%. These facts feed the 1-day and 1-week GLUE price prediction above.
Forecast Drivers
Monte Rosa Therapeutics Inc (GLUE) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches GLUE, ranked by similarity.
Seasonality analysis for GLUE
Historically the probability of a positive October return for GLUE is 45.76%. November offers the highest probability of a positive month at 100.00%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for GLUE
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $2.74 | $6.63 | $7.74 | -31.91% |
| Nov 2026 | $8.46 | $10.53 | $12.50 | +8.09% |
| Dec 2026 | $7.18 | $10.32 | $14.75 | +5.96% |
In 2026, Monte Rosa Therapeutics Inc (GLUE) is projected to range from $2.74 to $14.75.
Monte Rosa Therapeutics Inc 2026 monthly forecast
In Oct 2026, Monte Rosa Therapeutics Inc is projected to average $6.63, with a low of $2.74 and high of $7.74.
In Nov 2026, Monte Rosa Therapeutics Inc is projected to average $10.53, with a low of $8.46 and high of $12.50.
In Dec 2026, Monte Rosa Therapeutics Inc is projected to average $10.32, with a low of $7.18 and high of $14.75.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.